UC study finds racial disparities in pregnancy rates for kidney transplant recipients
Among women who are kidney transplant recipients, Hispanic women have a higher likelihood of pregnancy than white women, according to new research from the University of Cincinnati (UC). The study, published in the PLOS ONE journal, demonstrates the importance of understanding the factors responsible for these disparities in pregnancy rates.
“Child-bearing is an integral part of a woman’s life,” says Silvi Shah, MD, assistant professor in the Division of Nephrology, Kidney CARE Program in the Division of Internal Medicine at the UC College of Medicine and lead author of the study. “Although kidney transplant improves reproductive function in women with end-stage kidney disease (ESKD), pregnancy in patients with a kidney transplant is challenging due to risk of adverse maternal and fetal outcomes. Since pregnancy is not uncommon in kidney transplant recipients, it further becomes important to examine the racial differences and factors associated with pregnancy in this high-risk population.”
The study evaluated 7,966 women of childbearing age who received a kidney transplant between Jan. 1, 2005 and Dec. 31, 2011, using the United States Renal Data System. The study finds a pregnancy rate of 13.8 per-thousand person years (PTPY) overall, and Hispanic women were 56% more likely than white women to become pregnant.
Overall, 293 pregnancies were identified with a mean age of the study population at the time of transplant of just under 34 years. The rate of pregnancy was highest in Hispanic women (21.4 PTPY) followed by blacks (8.7 PTPY) and whites (7.8 PTPY). The overall rates of pregnancy were higher during the second and third year following the kidney transplant than the first year after the transplant. The study also showed that among transplant recipients, pregnancy was more likely in women with ESKD due to cystic disease or glomerulonephritis (an inflammation in the kidneys) as compared to women with ESKD due to diabetes. The type of donor, duration of dialysis and type of immunosuppression at transplant did not impact the likelihood of pregnancy.
Shah says the study is unique in that it evaluates a comprehensive racial group of patients in the first three years post-transplant to better understand the incidence of pregnancy and factors associated with it among kidney transplant patients. The study further took into account patients with complete Medicare coverage, thus avoiding the potential shortfalls of registries dependent on voluntary reporting or patient recall. The research shows for the first time that pregnancy rates in women with kidney transplants remained constant and did not show a decline, and, in fact, were higher than those shown in prior reports over the previous 10 years.
“This is telling us that there are additional factors, which could be cultural or biological, contributing to these racial differences,” Shah says. “While socioeconomic factors and health literacy could play an important role, the real reasons remain unknown. It is imperative to advocate for the inclusion of all races in all studies, and tailor therapies to specific biological states.”
Assisting in the research were Prasoon Verma, MD, from the Division of Neonatology at Cincinnati Children’s; Annette Christianson and Karthikeyan Meganathan, research associates in the Department of Biomedical Informatics; Anthony Leonard, PhD, research associate professor in the Department of Family and Community Medicine; Daniel Schauer, MD, associate professor in the Department of Internal Medicine; and Charuhas Thakar, MD, professor and director of the Division of Nephrology, Kidney C.A.R.E. Program, all in the UC College of Medicine.
Related Stories
Can Cincinnati become a Blue Zone?
February 12, 2026
Under the Blue Zones Project umbrella, 75 U.S. cities currently are working on group diet and exercise programs while also changing the community’s culture, so that residents are encouraged to make healthy choices. Cincinnati is not an official Blue Zones Project city yet, but Florence Rothenberg, MD, adjunct professor of cardiology at the University of Cincinnati College of Medicine and clinical cardiologist at the Cincinnati VA Medical Center, is leading one public effort to encourage a Blue Zone lifestyle. Her work was recently featured in Cincinnati Magazine.
Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment
February 12, 2026
MSN UK highlighted University of Cincinnati Cancer Center researchers studying the use of a delayed release preparation or wafer of an immunostimulatory molecule known as IL-15 to stimulate the central nervous system immune system after surgery to remove glioblastoma brain tumors.
UC’s research surges with $346M in awards
February 12, 2026
The University of Cincinnati reached $346 million in sponsored research awards in fiscal year 2025, up 6.6% increase over the previous year. Additionally, funding for clinical trials at UC climbed, with $88 million in industry-sponsored awards and $33 million in federally sponsored awards.